Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion

Journal of Urology

Volumn 174, Issue 2, 2005, Pages 557-560

  Stephenson, Andrew J ^a   Bosl, George J ^a   Bajorin, Dean F ^a   Stasi, Jason ^a   Motzer, Robert J ^a   Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Neoplasm staging; Neoplasms, germ cell and embryonal; Testicular neoplasms; Testis; Treatment outcome

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; CANCER INVASION; CANCER RELAPSE; CANCER STAGING; EMBRYONAL CARCINOMA; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL RATE; TERATOMA; TESTIS CANCER; YOLK SAC TUMOR;

EID: 22144495005     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000165163.03805.37     Document Type: Article

References (20)

1. Hermans, B. P., Sweeney, C. J., Foster, R. S., Einhorn, L. E. and Donohue, J. P.: Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol, 163: 1721, 2000
2. Nicolai, N., Miceli, R., Artusi, R., Piva, L., Pizzocaro, G. and Salvioni, R.: A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. J Urol, 171: 172, 2004
3. Amato, R. J., Ro, J. Y., Ayala, A. G. and Swanson, D. A.: Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Urology, 63: 144, 2004
4. Bohlen, D., Borner, M., Sonntag, R. W., Fey, M. F. and Studer, U. E.: Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol, 161: 1148, 1999
5. Oliver, R. T., Ong, J., Shamash, J., Ravi, R., Nagund, V., Harper, P. et al: Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy. Urology, 63: 556, 2004
6. Swanson, D. A., von Eschenbach, A. C., Babaian, R. J., Dinney, C. P. N., Pisters, L. L., Pettaway, C. A.: Is retroperitoneal lymph node dissection (RLND) alone optimal or sufficient therapy for clinical stage I nonseminomatous germ cell testicular tumors (NSGCTT) at high risk for relapse? J Urol, suppl., 159: 49, abstract 179, 1998
7. Heidenreich, A., Sesterhenn, I. A., Mostofi, F. K. and Moul, J. W.: Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer, 83: 1002, 1998
8. Foster, R. S., Baniel, J., Leibovitch, I., Curran, M., Bihrle, R., Rowland, R. et al: Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer. J Urol, 155: 1943, 1996
9. George, D. W., Foster, R. S., Hromas, R. A., Robertson, K. A., Vance, G. H., Ulbright, T. M. et al: Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol, 21: 113, 2003
10. Kondagunta, G. V., Sheinfeld, J., Mazumdar, M., Mariani, T. V., Bajorin, D., Bacik, J. et al. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. J Clin Oncol, 22: 464, 2004
11. Cullen, M. H., Stenning, S. P., Parkinson, M. C., Fossa, S. D., Kaye, S. B., Horwich, A. H. et al: Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol, 14: 1106, 1996
12. Meinardi, M. T., Gietema, J. A., van der Graaf, W. T., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J. et al: Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol, 18: 1725, 2000
13. Bajorin, D. F., Motzer, R. J., Rodriguez, E., Murphy, B. and Bosl, G. J.: Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst, 85: 60, 1993
14. Baniel, J., Foster, R. S., Rowland, R. G., Bihrle, R. and Donohue, J. P.: Complications of primary retroperitoneal lymph node dissection. J Urol, 152: 424, 1994
15. Donohue, J. P. and Foster, R. S.: Retroperitoneal lymphadenectomy in staging and treatment. The development of nervesparing techniques. Urol Clin North Am, 25: 461, 1998
16. Read, G., Stenning, S. P., Cullen, M. H., Parkinson, M. C., Horwich, A., Kaye, S. B. et al: Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol, 10: 1762, 1992
17. Sweeney, C. J., Hermans, B. P., Heilman, D. K, Foster, R. S., Donohue, J. P. and Einhorn, L. H.: Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma-predominant testis cancer. J Clin Oncol, 18: 358, 2000
18. Davis, B. E., Herr, H. W., Fair, W. R. and Bosl, G. J.: The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy. J Urol, 152: 111, 1994
19. Hao, D., Seidel, J., Brant, R., Alexander, F., Ernst, D. S., Summers, N. et al: Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol, 160: 768, 1998
20. Sogani, P. C., Perrotti, M., Herr, H. W., Fair, W. R., Thaler, H. T. and Bosl, G.: Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol, 159: 855, 1998